Renaissance Technologies’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
138,700
+4,300
| +3% | +$449K | 0.02% | 866 |
|
|
2025
Q1 | $15.7M | Buy |
+134,400
| New | +$15.7M | 0.02% | 769 |
|
|
2020
Q3 | – | Sell |
-66,400
| Closed | -$5.46M | – | 3368 |
|
|
2020
Q2 | $5.46M | Buy |
66,400
+14,300
| +27% | +$1.18M | ﹤0.01% | 1590 |
|
|
2020
Q1 | $3.07M | Buy |
52,100
+1,330
| +3% | +$78.2K | ﹤0.01% | 1833 |
|
|
2019
Q4 | $5.25M | Buy |
+50,770
| New | +$5.25M | ﹤0.01% | 1821 |
|
|
2019
Q3 | – | Sell |
-247,200
| Closed | -$6.37M | – | 3422 |
|
|
2019
Q2 | $6.37M | Buy |
+247,200
| New | +$6.37M | 0.01% | 1680 |
|
|
2019
Q1 | – | Sell |
-15,110
| Closed | -$43K | – | 3443 |
|
|
2018
Q4 | $43K | Buy |
+15,110
| New | +$43K | ﹤0.01% | 3296 |
|
|
2018
Q1 | – | Sell |
-48,400
| Closed | -$271K | – | 3363 |
|
|
2017
Q4 | $271K | Buy |
+48,400
| New | +$271K | ﹤0.01% | 3049 |
|